ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
3,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3,3,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
3,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,5,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
4,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
4,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
6,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
6,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
6,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
7,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
7,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
8,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
8,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
9,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,2,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
9,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
9,5,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
10,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
10,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
12,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
12,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
12,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
13,1,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
14,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
14,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,3,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
15,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
15,2,Serum sickness-like reaction,Allergic conditions NEC,Allergic conditions,Immun,N
15,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
16,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
16,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
17,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
18,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
19,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
19,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
20,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
21,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
22,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
22,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
23,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
23,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
23,3,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
23,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
23,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
23,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,8,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
23,9,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
23,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
23,11,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
23,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
23,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
23,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
24,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
24,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,4,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
24,5,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
24,6,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
24,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
24,8,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
24,9,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
25,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,2,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
25,3,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
25,4,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
25,5,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
25,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
25,7,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
25,8,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
26,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
26,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
26,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
26,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
26,5,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
26,6,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
26,7,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
26,8,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
27,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,2,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
27,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
27,4,Haemangioma of skin,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
27,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
27,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,7,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
27,8,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
27,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
28,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
28,2,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
28,3,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
29,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
29,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
30,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
30,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
30,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
30,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
31,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
31,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
31,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
31,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
31,5,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
32,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
34,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
34,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
34,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
35,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
35,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
35,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,1,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
37,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
37,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
37,3,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
37,4,Oesophageal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
37,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
38,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
38,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
38,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
39,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
39,3,Headache,Headaches NEC,Headaches,Nerv,N
39,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
39,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
40,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
40,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
40,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,4,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
40,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
41,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
41,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
41,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
41,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
42,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
42,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
42,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
42,5,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
42,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
42,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
42,8,Vascular pseudoaneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
43,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
43,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
43,4,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
43,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
44,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
44,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
45,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
45,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
45,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
46,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
47,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
47,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
48,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
48,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
48,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
49,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
49,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
49,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
50,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
50,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
51,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
51,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
51,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
52,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
52,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
52,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
52,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
52,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
